Distribution of rotavirus genotypes causing nosocomial and community-acquired acute gastroenteritis at the Children's Hospital of Philadelphia in the new rotavirus vaccine era

Human Vaccines

Volumn 7, Issue 11, 2011, Pages 1118-1123

  Clark, H Fred ^a   Lawley, Diane ^a   DiStefano, Daniel ^b   Matthijnssens, Jelle ^c   DiNubile, Mark J ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

CHOP; Gastroenteritis; Rotavirus; Serotypes; Vaccine

Indexed keywords

ROTAVIRUS VACCINE; VIRUS ANTIGEN;

ACUTE GASTROENTERITIS; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FECES ANALYSIS; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HOSPITAL INFECTION; HUMAN; INFANT; NUCLEOTIDE SEQUENCE; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; ROTAVIRUS; SEASONAL VARIATION; SEROTYPE; SPECIES DISTRIBUTION; UNITED STATES; VIRAL GASTROENTERITIS; VIRUS STRAIN;

EID: 81855189576     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.11.17820     Document Type: Article

References (41)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-72; PMID:12737740.
2. Centers for Disease Control. Rotavirus surveillance - worldwide, 2001-2008. MMWR Morb Mortal Wkly Rep 2008; 57:1255-7; PMID:19023263.
3. Parashar UD, Glass RI. Rotavirus vaccines - early success, remaining questions. N Engl J Med 2009; 360:1063-5; PMID:19279338; DOI:10.1056/ NEJMp0810154.
4. Danchin MH, Bines JE. Defeating rotavirus? The global recommendation for rotavirus vaccination. N Engl J Med 2009; 361:1919-21; PMID:19907040; DOI:10.1056/NEJMp0905091.
5. Velázquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996; 335:1022-8; PMID:8793926; DOI:10.1056/NEJM199610033351404.
6. Clark HF, Lawley DA, Mallette LA, DiNubile MJ, Hodinka RL. Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine. Clin Vaccine Immunol 2009; 16:382-6; PMID:19158283; DOI:10.1128/CVI.00382-08.
7. Clark HF, Marcello AE, Lawley D, Reilly M, DiNubile MJ. Unexpectedly high burden of rotavirus gastroenteritis in very young. BMC Pediatr 2010; 10:40; PMID:20540748; DOI:10.1186/1471-2431-10-40.
8. Fischer TK, Viboud C, Parashar U, Malek M, Steiner C, Glass R, et al. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis 2007; 195:1117-25; PMID:17357047; DOI:10.1086/512863.
9. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33; PMID:16394299; DOI:10.1056/NEJMoa052664.
10. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22; PMID:16394298; DOI:10.1056/NEJMoa052434.
11. Clark HF, Lawley DA, Schaffer A, Patacsil JM, Marcello AE, Glass RI, et al. Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol 2004; 42:1434-8; PMID:15070985; DOI:10.1128/JCM.42.4.1434-8.2004.
12. Clark HF, Lawley D, DiStefano D, Maliga M, Kilby B, Kulnis G, et al. An unusual outbreak of rotavirus genotype G2P[6] during the 2005-2006 epidemic season in Philadelphia. Diagn Microbiol Infect Dis 2011; In press; PMID:21398071; DOI:10.1016/j. diagmicrobio.2010.12.014.
13. Clark HF, Lawley D, Matthijnssens J, DiNubile MJ, Hodinka RL. Sustained decline in cases of rotavirus gastroenteritis presenting to the Children's Hospital of Philadelphia in the new rotavirus vaccine era. Pediatr Infect Dis J 2010; 29:699-702; PMID:20661099; DOI:10.1097/INF.0b013e3181d73524.
14. Matthijnssens J, Joelsson DB, Warakomski DJ, Zhou T, Mathis PK, van Maanen MH, et al. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 2010; 403:111-27; PMID:20451234; DOI:10.1016/j. virol.2010.04.004.
15. DiStefano DJ, Kraiouchkine N, Mallette L, Maliga M, Kulnis G, Keller PM, et al. Novel rotavirus VP7 typing assay using a one-step reverse transcriptase PCR protocol and product sequencing and utility of the assay for epidemiological studies and strain characterization, including serotype subgroup analysis. J Clin Microbiol 2005; 43:5876-80; PMID:16333070; DOI:10.1128/ JCM.43.12.5876-80.2005.
16. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30:1365-73; PMID:1320625.
17. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10; PMID:2231712.
18. Centers for Disease Control. Reduction in rotavirus after vaccine introduction-United States, 2000-2009. MMWR Morb Mortal Wkly Rep 2009; 58:1146-9; PMID:19847149.
19. Centers for Disease Control. Rotavirus vaccination coverage among infants aged 5 months - immunization information system sentinel sites, United States, June 2006 - June 2009. MMWR Morb Mortal Wkly Rep 2010; 59:521-4; PMID:20448529.
20. Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010; 125:199-207; PMID:20083525; DOI:10.1542/peds.2009-1021.
21. Tate JE, Mutuc JD, Panozzo CA, Rench MA, Hull JJ, Gentsch JR, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30:30-4; PMID:21183838; DOI:10.1097/INF.0b013e3181ffe3eb.
22. Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus- associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's national childhood vaccine schedule. Pediatr Infect Dis J 2011; 30:25-9; PMID:21183837; DOI:10.1097/ INF.0b013e3181fefdee.
23. Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the national immunization program of Australia. Pediatr Infect Dis J 2011; 30:48-53; PMID:21183840; DOI:10.1097/INF.0b013e3181fefd90.
24. Ngo TC, Nguyen BM, Dang DA, Nguyen HT, Nguyen TT, Tran VN, et al. Molecular epidemiology of rotavirus diarrhoea among children in Haiphong, Vietnam: the emergence of G3 rotavirus. Vaccine 2009; 27:75-80; PMID:19931725.
25. Phan TG, Trinh QD, Khamrin P, Kaneshi K, Ueda Y, Nakaya S, et al. Emergence of new variant rotavirus G3 among infants and children with acute gastroenteritis in Japan during 2003-2004. Clin Lab 2007; 53:41-8; PMID:17323824.
26. Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, et al. United States rotavirus strain surveillance from 2005 to 2009. Genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011; 30:42-7; PMID:21183839; DOI:10.1097/ INF.0b013e3181fefd78.
27. Gentsch JR, Laird AR, Bielfelt B, Griffin DD, Banyai K, Ramachandran M, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005; 192:146-59; PMID:16088798; DOI:10.1086/431499.
28. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 1999; 5:336-45; PMID:10341170; DOI:10.3201/eid0503.990304.
29. Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Bányai K, Rahman M, et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol 2009; 4:1303-16; PMID:19995190; DOI:10.2217/ fmb.09.96.
30. Patel MM, Parashar UD. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. J Infect Dis 2009; 200:291-9; PMID:19817612; DOI:10.1086/605059.
31. Dagan R. Serotype replacement in perspective. Vaccine 2009; 27:22-4; PMID:19545935; DOI:10.1016/j.vaccine.2009.06.004.
32. Mera R, Miller LA, Fritsche TR, Jones RN. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb Drug Resist 2008; 14:101-7; PMID:18491947; DOI:10.1089/mdr.2008.0782.
33. Zeller M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, et al. J Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 2010; 28:7507-13; PMID:20851085; DOI:10.1016/j.vaccine.2010.09.004.
34. Hanage WP, Finkelstein JA, Huang SS, Pelton SI, Stevenson AE, Kleinman K, et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2010; 2:80-4; PMID:21031138; DOI:10.1016/j.epidem.2010.03.005.
35. Matthijnssens J, Heylen E, Zeller M, Rahman M, Lemey P, Van Ranst M. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Mol Biol Evol 2010; 27:2431-6; PMID:20522727; DOI:10.1093/molbev/msq137.
36. Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010; 29:489-94; PMID:20354464.
37. Christie CD, Duncan ND, Thame KA, Onorato MT, Smith HD, Malcolm LG, et al. Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilization. Pediatrics 2010; 126:1499-506; PMID:21115586; DOI:10.1542/peds.2010-1240.
38. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010; 362:299-305; PMID:20107215; DOI:10.1056/NEJMoa0905211.
39. Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98; PMID:20107214; DOI:10.1056/NEJMoa0904797.
40. Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14; PMID:20692030; DOI:10.1016/S0140-6736(10)60889-6.
41. Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-23; PMID:20692031; DOI:10.1016/S0140-6736(10)60755-6.